Status:

COMPLETED

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Parkinson Disease

Eligibility:

All Genders

20+ years

Phase:

PHASE4

Brief Summary

Study to assess the safety, tolerability and effectiveness of a switching from Domin® (talipexole) tablet to BI Sifrol® (pramipexole) tablet in patients with Parkinson's disease

Eligibility Criteria

Inclusion

  • Diagnosis of Parkinson's disease (included juvenile parkinsonism) and treated with talipexole (Domin®)
  • Patients who present stable symptoms and maintain the doses of talipexole and other concomitant therapy for Parkinson's disease at least last 4 weeks
  • Male or female patients aged 20 and over
  • In or out-patients
  • Patient's severity characterized as Stage 1 - 5 by Modified Hoehn \& Yahr scale
  • Ability to provide written informed consent in accordance with the Good Clinical Practice (GCP), Good Post-marketing Surveillance Practice (GPMSP) and other relevant laws such as the Pharmaceutical Affairs Law

Exclusion

  • History of hypersensitivity of pramipexole
  • Psychiatric symptoms such as confusion, hallucination, delusion, agitation, delirium and abnormal behavior
  • Subjective symptom derived from orthostatic hypotension
  • Hypotension (systolic blood pressure; 100 mmHg or less)
  • Complication such as clinically significant cardiac, renal and hepatic diseases
  • Patients who drive a car, operate a machine, work on heights or engage in other hazardous activities
  • Pregnant, possibly pregnant or female in lactation
  • Patients who are participating in other drug studies or who receive other investigational drugs within last 3 months before enrolled this study
  • Other than above, those who judged by the investigator or sub-investigator to be inappropriate as for the study

Key Trial Info

Start Date :

January 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT02231905

Start Date

January 1 2004

Last Update

September 4 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease | DecenTrialz